Insulet
PODD • NASDAQ
Insulet is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Ashley A. McEvoy, with a market cap of $16.7B.
CEOAshley A. McEvoy
Market Cap$16.7B
Medical - Devices
Healthcare
Employees3.0K
Websiteinsulet.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Insulet
Date
Thursday, May 7, 2026 (in 2 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
$1.18
Revenue Estimate
$728.8M
Earnings History
Past 12 earnings reports for Insulet
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 18, 2026 | Q4 2025 | $1.55Est: $1.47 | +5.4% | $783.8MEst: $768.2M | +2.0% |  10-K |
| Nov 6, 2025 | Q3 2025 | $1.24Est: $1.14 | +8.8% | $706.3MEst: $678.0M | +4.2% | 10-Q |
| Aug 7, 2025 | Q2 2025 | $1.17Est: $0.93 | +25.8% | $649.1MEst: $613.6M | +5.8% | 10-Q |
| May 8, 2025 | Q1 2025 | $1.02Est: $0.79 | +29.1% | $569.0MEst: $543.3M | +4.7% | 10-Q |
| Feb 20, 2025 | Q4 2024 | $1.15Est: $1.02 | +12.7% | $597.5MEst: $582.0M | +2.7% | 10-K |
| Nov 7, 2024 | Q3 2024 | $0.90Est: $0.76 | +18.4% | $543.9MEst: $518.3M | +4.9% | 10-Q |
| Aug 8, 2024 | Q2 2024 | $0.55Est: $0.56 | -1.8% | $488.5MEst: $459.9M | +6.2% | 10-Q |
| May 9, 2024 | Q1 2024 | $0.73Est: $0.39 | +87.2% | $441.7MEst: $424.1M | +4.2% | 10-Q |
| Feb 22, 2024 | Q4 2023 | $1.40Est: $0.66 | +112.1% | $509.8MEst: $460.5M | +10.7% | 10-K |
| Nov 2, 2023 | Q3 2023 | $0.71Est: $0.40 | +77.5% | $432.7MEst: $414.2M | +4.5% | — |
| Aug 8, 2023 | Q2 2023 | $0.38Est: $0.24 | +58.3% | $396.5MEst: $384.0M | +3.3% | 10-Q |
| May 4, 2023 | Q1 2023 | $0.23Est: $0.11 | +109.1% | $358.1MEst: $330.8M | +8.2% | — |